business

As globe gallops into vaccine trials, insurers remain unfazed

2 Comments
By Noor Zainab Hussain, Carolyn Cohn and Ludwig Burger

The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.

© Thomson Reuters 2020.

©2024 GPlusMedia Inc.

2 Comments
Login to comment

The US do not even have the infrastructure to distribute the vaccine, the money has not been approved nor the distribution or needed storage

0 ( +1 / -1 )

Such have been the worries about the vaccine race among some members of the public, who fear safety standards could slip, that nine developers issued a joint pledge last month to "uphold the integrity of the scientific process".

How about not having the hapless individuals, contributing their health, not sign a waiver?

If side effects are so ‘rare’ what is the problem?

“scientific integrity” does not mean acceptance of liability, does it?

Pharmaceutical companies make huge profits from people putting their health at risk in clinical trials yet always seek to limit responsibility.

The profits from a successful safe vaccine against Covid-19 will be phenomenal!

Something is not right!

1 ( +2 / -1 )

Login to leave a comment

Facebook users

Use your Facebook account to login or register with JapanToday. By doing so, you will also receive an email inviting you to receive our news alerts.

Facebook Connect

Login with your JapanToday account

User registration

Articles, Offers & Useful Resources

A mix of what's trending on our other sites